Dorsey Wright & Associates’s Medifast MED Stock Holding History

Dorsey Wright & Associates’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-195	Closed	-$43K	–	319
2018 Q3	$43K	Buy	+195	New	+$39.5K	0.01%	121

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dorsey Wright & Associates's MED Position: Q4 2018 in Review

Dorsey Wright & Associates sold out of Medifast (MED) in Q4 2018, closing a stake of 195 shares — an estimated $43K sold.

Dorsey Wright & Associates first reported a position in MED in Q3 2018 and held it in 1 quarter. The position peaked at $43K in Q3 2018. 247 funds tracked by Wall St. Rank hold MED as of Q4 2018.

Dorsey Wright & Associates reported no remaining Medifast position as of Q4 2018 after selling out during the quarter.
Dorsey Wright & Associates sold 195 Medifast shares in Q4 2018, an estimated $43K.
Dorsey Wright & Associates first reported a position in Medifast in Q3 2018 and held it in 1 quarter.
Dorsey Wright & Associates's Medifast position peaked at $43K in Q3 2018.
247 funds tracked by Wall St. Rank held Medifast as of Q4 2018.

Based on Dorsey Wright & Associates's 13F filing for Q4 2018, filed 7 Jan 2019.